Literature DB >> 15522939

Giant insulinoma: case report and review of the literature.

Elizabeth A Mittendorf1, Yao-Chang Liu, Christopher R McHenry.   

Abstract

An insulinoma is a rare pancreatic endocrine tumor that is typically sporadic, solitary, and less than 2 cm in diameter. Fewer than 5% of insulinomas are larger than 3 cm. Ninety percent or more of all insulinomas are benign. Larger tumors are more likely to be malignant. We report a case of a giant pedunculated insulinoma, measuring 9 cm in diameter and weighing 100 g, with amyloid deposits accounting for 70% of the tumor volume. At the time of operation, no local invasion or metastatic disease was identified. On pathological evaluation, the tumor was classified as an insulinoma of uncertain biological behavior. In addition to describing the clinical presentation and operative findings, criteria for determining malignancy are outlined, a detailed pathological description is presented, and the 2000 World Health Organization Classification for Pancreatic Endocrine Neoplasms is reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522939     DOI: 10.1210/jc.2004-0825

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Diagnosis and management of insulinoma.

Authors:  Takehiro Okabayashi; Yasuo Shima; Tatsuaki Sumiyoshi; Akihito Kozuki; Satoshi Ito; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

2.  Intra-arterial calcium stimulation test with hepatic venous sampling for preoperative diagnosis of a large insulinoma in an obese young man.

Authors:  Ya-Cheng Chen; Chang-Hsien Liu; Chih-Yung Yu; Guo-Shu Huang
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

3.  Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution.

Authors:  Jishu Wei; Xinchun Liu; Junli Wu; Wenbin Xu; Wentao Gao; Kuirong Jiang; Zhihong Zhang; Yi Miao
Journal:  Langenbecks Arch Surg       Date:  2016-08-19       Impact factor: 3.445

4.  Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review.

Authors:  Benedetto Ielpo; Riccardo Caruso; Valentina Ferri; Yolanda Quijano; Hipolito Duran; Eduardo Diaz; Isabel Fabra; Ramon Puga; Catalina Oliva; Sergio Olivares; Emilio Vicente
Journal:  Int J Surg Case Rep       Date:  2012-12-11

5.  Recurrent hypoglycaemia in a type 2 diabetes patient - diagnostic difficulties.

Authors:  Joanna Grycewicz; Zdzistawa Scibór; Jarosław B Cwikła; Andrzej Lewiński; Katarzyna Cypryk
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

6.  Giant insulinoma: report of a case and review of published reports.

Authors:  Kazumitsu Ueda; Tetsuro Taira; Hiroyuki Hakoda; Shoko Nakata; Shinya Okata; Takeshi Nagai; Shigeo Aoki; Hideyuki Mishima; Akihiko Sako; Tsunehiko Maruyama; Minoru Okumura
Journal:  Surg Case Rep       Date:  2016-11-19

7.  Insulinoma causing liver metastases 15 years after initial surgery, accompanied by glomerulonephritis.

Authors:  A Janez
Journal:  Case Rep Endocrinol       Date:  2012-12-03

8.  Concomitant existence of pheochromocytoma in a patient with multiple endocrine neoplasia type 1.

Authors:  Ryo Okada; Tatsuo Shimura; Shigeyuki Tsukida; Jin Ando; Yasuhide Kofunato; Tomoyuki Momma; Rei Yashima; Yoshihisa Koyama; Shinichi Suzuki; Seiichi Takenoshita
Journal:  Surg Case Rep       Date:  2016-08-30

Review 9.  Malignant insulinoma with hepatic and pulmonary metastases associated with primary hyperparathyroidism. Case report and review of the literature.

Authors:  A Albu; A Zirnea; O Georgescu; D Terzea; D Jinga; S Fica
Journal:  J Med Life       Date:  2008 Apr-Jun

10.  [High grade insulinoma detected in a patient with a 5-year history of severe hypoglycemias].

Authors:  Nadia Anoun; Hamza Hasnaoui; Firdaous Ameziane Hassani; Mehdi Bourakkadi Idrissi; Abdelmalek Ousadden; Hanan El Ouahabi; Khalid Ait Taleb
Journal:  Pan Afr Med J       Date:  2017-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.